Healthcare / Medical Care FacilitiesNasdaqGS
$13.09
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $111.4M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$406M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-29.4%
↓Gross Margin
20.3%
↓Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
3.8%
FCF / Net income
-0.42x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.05B · net income $-94.9M · FCF $40.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $1.05B | $1.05B | $1.34B | $2.02B | $2.80B | $1.68B | $836.4M | $822.2M | $816.5M | $865.0M | $833.5M | — | — | — | — | — | — | — |
| Net Income | $-94.9M | $-94.9M | $-14.6M | $72.6M | $186.0M | $132.0M | $-13.0M | $-57.7M | $-17.0M | $37.5M | $8.0M | $4.4M | $-31.8M | $-52.0M | $-42.2M | $4.1M | $-2.8M | $6.7M |
| EBITDA | $-64.5M | $-64.5M | $4.0M | $129.3M | $280.1M | $149.2M | $3.5M | $-1.6M | $-1.1M | $21.9M | $15.4M | $28.6M | $-3.0M | — | — | — | — | — |
| EPS | -2.93 | -2.93 | -0.44 | 2.05 | 5.02 | 3.53 | -0.36 | -1.61 | -0.48 | 1.01 | 0.15 | 0.14 | -1.02 | -1.68 | -1.37 | 0.13 | -0.09 | 0.22 |
| Gross Margin | 20.3% | 20.3% | 20.4% | 22.3% | 22.3% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | -0.4% | -0.4% | 1.7% | 6.5% | 10.3% | 8.3% | -1.1% | -1.9% | -1.6% | 1.4% | 0.7% | — | — | — | — | — | — | — |
| Net Margin | -9.0% | -9.0% | -1.1% | 3.6% | 6.6% | 7.9% | -1.5% | -7.0% | -2.1% | 4.3% | 1.0% | — | — | — | — | — | — | — |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.35 | 0.62 | 0.36 | 0.44 | 0.36 | 0.39 | 0.56 | — | — | — | — | — | — | — |
| Current Ratio | 3.29 | 3.29 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $40.1M | $40.1M | $111.4M | $234.5M | $125.3M | $-92.8M | $22.6M | $2.6M | $16.4M | $40.4M | $23.6M | $15.9M | $-8.6M | $6.9M | $7.9M | $14.3M | $29.1M | — |
| Returns | ||||||||||||||||||
| ROE | -29.4% | -29.4% | -3.5% | 15.5% | 40.7% | 44.9% | -8.4% | -35.5% | -7.8% | 15.8% | 5.3% | 3.1% | -24.5% | -32.3% | -20.2% | 1.6% | -1.1% | 2.7% |
| Valuation | ||||||||||||||||||
| P/E | — | — | — | 11.09 | 5.71 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | — | — | 132.85 | 6.14 | 4.39 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.31 | 1.31 | 1.45 | 1.72 | 2.35 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | -21.6% | -21.6% | -33.5% | -28.0% | — | 100.5% | 1.7% | 0.7% | -5.6% | 3.8% | — | — | — | — | — | — | — | — |
| EPS Growth | -565.9% | -565.9% | -121.5% | -59.2% | — | 1080.6% | 77.6% | -235.4% | -147.5% | 573.3% | 7.1% | 113.7% | 39.3% | -22.6% | -1153.8% | 244.4% | -140.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-0.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.44 → -2.93
Residual
-0.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.